To Prescribe or Not? Pharmacological Options in Adult Attention-Deficit/Hyperactivity Disorder
Abstract
As children with attention-deficit/hyperactivity disorder (ADHD) age out of childhood and adolescence and into adulthood, their symptoms often persist. Faced with increasing demands from modern life, these patients often request treatment to help optimize functioning in work and home settings. The aim of treating adult ADHD is to help patients control distraction/inattention and to minimize psychomotor agitation. Once the diagnosis of ADHD is ascertained in adults, general treatment principles, including use of stimulants, should be followed but they must be weighed against an increased risk of diversion of stimulant medications in adults. Stimulants include amphetamines (with the closely related methylphenidate formulations often thought of as stimulants as well despite a different mechanism of action) and constitute the gold standard in treatment of ADHD. Nonstimulants such as atomoxetine, however, can play an extremely important role in treatment as well. [ Psychiatr Ann. 2017;47(6):303–308.]
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
By inhibiting DA and NE reuptake and facilitating presynaptic release, stimulants normalize the deficient cortical arousal and signal-to-noise ratios characteristic of ADHD.
“By inhibiting DA and NE reuptake and facilitating presynaptic release, stimulants normalize the deficient cortical arousal and signal-to-noise ratios characteristic of ADHD [145].”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [145]
Stimulants act primarily through enhancement of catecholaminergic neurotransmission in prefrontal and striatal regions critical for attention and executive control.
“both acting primarily through enhancement of catecholaminergic neurotransmission in prefrontal and striatal regions critical for attention and executive control”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [145]
Cites
FARAONE, S. V., BIEDERMAN, J., & MICK, E. (2006) · Psychological Medicine · doi:10.1017/s003329170500471x · Cited by 2,267 · see citing works
Amphetamine, past and present – a pharmacological and clinical perspective
Heal, D. J., Smith, S. L., Gosden, J., & Nutt, D. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113482532 · Cited by 622 · see citing works
Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review
Kollins, S. H., MacDonald, E. K., & Rush, C. R. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00464-6 · Cited by 365 · see citing works
Bonvicini, C., Faraone, S. V., & Scassellati, C. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.74 · Cited by 240 · see citing works
Adult Attention Deficit–Hyperactivity Disorder
Volkow, N. D., & Swanson, J. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1212625 · Cited by 227 · see citing works
Taylor, F. B., & Russo, J. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00015 · Cited by 189 · see citing works
Stimulant Drugs and ADHD: Basic and Clinical Neuroscience
Durant, N. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1959-a · Cited by 180 · see citing works
Treatment of adults with attention-deficit/hyperactivity disorder
Hechtman, L. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s6985 · Cited by 157 · see citing works
Wang, G.-J., Volkow, N. D., Wigal, T., Kollins, S. H., Newcorn, J. H., Telang, F., Logan, J., Jayne, M., Wong, C. T., Han, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063023 · Cited by 144 · see citing works
Young, Z., Moghaddam, N., & Tickle, A. (2020) · Journal of Attention Disorders · doi:10.1177/1087054716664413 · Cited by 138 · see citing works
Bond, D. J., Hadjipavlou, G., Lam, R. W., McIntyre, R. S., Beaulieu, S., Schaffer, A., & Weiss, M. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400104 · Cited by 133 · see citing works
Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder
Fone, K. C. F., & Nutt, D. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.10.001 · Cited by 110 · see citing works
Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults
Castells, X., Ramos-Quiroga, J. A., Bosch, R., Nogueira, M., & Casas, M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007813.pub2 · Cited by 80 · see citing works
Long-Term Safety and Effectiveness of Mixed Amphetamine Salts Extended Release in Adults With ADHD
Biederman, J., Spencer, T. J., Wilens, T. E., Weisler, R. H., Read, S. C., & Tulloch, S. J. (2005) · CNS Spectrums · doi:10.1017/s1092852900002406 · Cited by 79 · see citing works
Bedard, A., Stein, M. A., Halperin, J. M., Krone, B., Rajwan, E., & Newcorn, J. H. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12272 · Cited by 62 · see citing works
Cortese, S., Adamo, N., Jensen, C. M., Hayes, A. J., Bhatti, S., Carucci, S., Giovane, C. D., Atkinson, L. Z., Banaschewski, T., Simonoff, E. A., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013967 · Cited by 45 · see citing works
Kaplan & Sadock's Pocket Handbook of Psychiatric Drug Treatment
Sadock, B. J., Sadock, V. A., & Sussman, N. (2001) · Cited by 41 · see citing works
Case Studies: Stahl's Essential Psychopharmacology
Stahl, S. M., & Muntner, N. (2011) · Cambridge University Press eBooks · doi:10.1017/9780521182089 · Cited by 36 · see citing works
Fredriksen, M., & Peleikis, D. E. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12477 · Cited by 31 · see citing works
Bushe, C., Day, K., Reed, V., Karlsdotter, K., Berggren, L., Pitcher, A., Televantou, F., & Haynes, V. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636105 · Cited by 31 · see citing works
Butterfield, M. E., Saal, J., Young, B., & Young, J. L. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.12.017 · Cited by 28 · see citing works
Coaching for College Students with ADHD
Prevatt, F. F. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-016-0751-9 · Cited by 27 · see citing works
Ravishankar, V., Chowdappa, S. V., Benegal, V., & Muralidharan, K. (2016) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2016.08.017 · Cited by 19 · see citing works
Flagged first, then by citations
1 of the 24 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives
Bogdańska-Chomczyk, E., Majewski, M. K., & Kozłowska, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211020 · Cited by 15 · see citing works
“By inhibiting DA and NE reuptake and facilitating presynaptic release, stimulants normalize the deficient cortical arousal and signal-to-noise ratios characteristic of ADHD [145].”
- Authors
- Aoshima-Kilroy, A., Banu, S., Udoetuk, S., Shah, A. A., & Moukaddam, N.
- Venue
- Psychiatric Annals
- Publisher
- SLACK, Inc.
- Published
- 2017-06
- Volume
- 47
- Issue
- 6
- Pages
- 303-308
- ISSN
- 0048-5713 (ISSN-L)
- 1938-2456
- OpenAlex
- W2623975861
- Cited by
- 1
- References
- 24
- Citations by year
- 2025: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychiatric Annals (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neuroethics, Human Enhancement, Biomedical Innovations
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- adult ADHD, pharmacotherapy, stimulants, amphetamine, methylphenidate, atomoxetine, non-stimulant medication, inattention, psychomotor agitation, drug prescribing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review